Cresud Stock Trades at $12.74 Amid Insider Selling and Analyst Ratings Update
1 report, 1 independent
Updated Sep 23
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cresud S.A.C.I.F. y A. shares traded at $12.74 on September 23, 2026, remaining above their 200-day moving average. The company previously reported Q2 earnings on August 15th, showing $1.14 EPS on revenue of $231.08 million. Separately, Weiss Ratings maintained a 'hold (c)' rating on the stock.
From tickerreport.com
Why it matters
The company is listed on the Nasdaq stock exchange and is subject to regulatory oversight by the SEC. Director Fernando Elsztain sold 65,000 shares of Cresud between September 1st and September 10th at an average price of $1.25 per share.
From tickerreport.com
Who's involved
- CresudArgentina agribusiness company whose stock is traded on the Nasdaq.
Keep exploring
The entities involved
-
Cresud
Argentina agribusiness company
Nothing else this week.
-
MarketBeat
American personal finance blog
Related events
- MarketBeat reports on company ratings and targets for Nikon Corporation and Jabil, comparing business profiles and financial health.
- MarketBeat used its screener tool to highlight company performance for Nu Holdings Ltd.
- MarketBeat is tracking company data, and Keefe, Bruyette & Woods is providing research coverage on Northrim BanCorp Inc.
- Co-Diagnostics filed a stock purchase with the SEC and received stock rating data from MarketBeat.
- Raymond James Financial provided research reports on Alignment Healthcare, Inc., whose stock trades on Nasdaq, with data reported on MarketBeat.